<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00608283</url>
  </required_header>
  <id_info>
    <org_study_id>DAIT RELIVE-01</org_study_id>
    <nct_id>NCT00608283</nct_id>
  </id_info>
  <brief_title>Live Kidney Donor Study</brief_title>
  <official_title>Live Kidney Donor Study (RELIVE-01)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Resources and Services Administration (HRSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Kidney transplants from living donors now account for 40% of all the kidney transplants done&#xD;
      in the United States. However, the current information on how donating a kidney can affect&#xD;
      the donor's long term health needs further investigation. The purpose of this study is to&#xD;
      collect data on a large number of live kidney donors and create and analyze a comprehensive&#xD;
      database. Information about the number of living kidney donors, including those who have&#xD;
      experienced kidney failure, heart problems, and death will be gathered for the database.&#xD;
      Investigators will then use the database to identify the risks of kidney failure, associated&#xD;
      conditions, and death after living donation. The database will also be used to identify&#xD;
      characteristics that put donors at higher risk for health problems after donation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Kidney transplantation is the preferred treatment to dialysis for most people with kidney&#xD;
      failure. However, the current waiting time to receive a kidney from a deceased donor is&#xD;
      greater than 5 years in some parts of the United States. Kidneys from living donors have&#xD;
      increased the number of kidneys available for transplantation and decreased the waiting&#xD;
      period for those needing a transplant. Living kidney donation also provides several&#xD;
      advantages over deceased donor kidneys, including more timely transplantation and longer&#xD;
      function of the transplanted kidney. Despite these facts, there is inadequate information&#xD;
      about whether living kidney donation may have serious adverse effects on the donor's health.&#xD;
      Long-term data on the health risks of living donation are needed.&#xD;
&#xD;
      The purpose of this study is to establish and analyze a database of information on living&#xD;
      donors who have or are going to donate a kidney at three transplant centers with longstanding&#xD;
      live kidney donation programs through June 2011. Donor and recipient characteristics as well&#xD;
      as specific data on kidney failure, heart disease, and death will be collected. National&#xD;
      databases such as the Scientific Registry of Transplant Recipients, the Social Security Death&#xD;
      Master File, the National Death Index and records maintained by the Centers for Medicare and&#xD;
      Medicaid Services for patients with end stage renal disease (ESRD) will be used to supplement&#xD;
      data provided by the participating transplant centers. After establishing the database,&#xD;
      researchers expect to 1) determine the long-term risk of live kidney donation and 2) identify&#xD;
      donor characteristics associated with higher risk for health problems after donation. Death,&#xD;
      cause of death, and incidence of ESRD will be compared to those rates reported by the Centers&#xD;
      for Disease Control and Prevention for the U.S. population during the same time period.&#xD;
&#xD;
      There will be no study visits for this study. Investigators will gather data from the medical&#xD;
      charts of all live kidney donors from the three transplant centers through June 2011.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall mortality</measure>
    <time_frame>Throughout study</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cause-specific mortality</measure>
    <time_frame>Throughout study</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>End stage renal disease as defined in the protocol</measure>
    <time_frame>Throughout study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular and renal morbidity</measure>
    <time_frame>Throughout study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 months incidence of adverse events</measure>
    <time_frame>At 6 months after kidney donation</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8951</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Live Kidney Donors</arm_group_label>
    <description>People who are going to donate a kidney at one of the three transplant centers from August 2007 until June 2011</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        People who will donate kidneys at one of the three transplant centers between August 2007&#xD;
        and June 2011&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Donated kidney at one of the three participating study centers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra J. Taler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Nephrology and Hypertension, Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clifton Kew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hassan Ibrahim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.niaid.nih.gov/</url>
    <description>National Institute of Allergy and Infectious Diseases (NIAID)</description>
  </link>
  <link>
    <url>https://www.niaid.nih.gov/about/dait</url>
    <description>Division of Allergy, Immunology, and Transplantation (DAIT)</description>
  </link>
  <link>
    <url>http://www.hrsa.gov/</url>
    <description>Health Resources and Services Administration (HRSA)</description>
  </link>
  <link>
    <url>https://www.nhlbi.nih.gov/</url>
    <description>National Heart, Lung, and Blood Institute (NHLBI)</description>
  </link>
  <reference>
    <citation>Baid-Agrawal S, Frei UA. Living donor renal transplantation: recent developments and perspectives. Nat Clin Pract Nephrol. 2007 Jan;3(1):31-41. Review.</citation>
    <PMID>17183260</PMID>
  </reference>
  <reference>
    <citation>Fehrman-Ekholm I, Nordén G, Lennerling A, Rizell M, Mjörnstedt L, Wramner L, Olausson M. Incidence of end-stage renal disease among live kidney donors. Transplantation. 2006 Dec 27;82(12):1646-8.</citation>
    <PMID>17198252</PMID>
  </reference>
  <reference>
    <citation>Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation. 2007 Mar 15;83(5):600-6.</citation>
    <PMID>17353781</PMID>
  </reference>
  <results_reference>
    <citation>Taler SJ, Messersmith EE, Leichtman AB, Gillespie BW, Kew CE, Stegall MD, Merion RM, Matas AJ, Ibrahim HN; RELIVE Study Group. Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant. 2013 Feb;13(2):390-8. doi: 10.1111/j.1600-6143.2012.04321.x. Epub 2012 Nov 8.</citation>
    <PMID>23137211</PMID>
  </results_reference>
  <results_reference>
    <citation>Jacobs CL, Gross CR, Messersmith EE, Hong BA, Gillespie BW, Hill-Callahan P, Taler SJ, Jowsey SG, Beebe TJ, Matas AJ, Odim J, Ibrahim HN; RELIVE Study Group. Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2221-31. doi: 10.2215/CJN.07120714. Epub 2015 Oct 13.</citation>
    <PMID>26463883</PMID>
  </results_reference>
  <results_reference>
    <citation>Jowsey SG, Jacobs C, Gross CR, Hong BA, Messersmith EE, Gillespie BW, Beebe TJ, Kew C, Matas A, Yusen RD, Hill-Callahan M, Odim J, Taler SJ; RELIVE Study Group. Emotional well-being of living kidney donors: findings from the RELIVE Study. Am J Transplant. 2014 Nov;14(11):2535-44. doi: 10.1111/ajt.12906. Epub 2014 Oct 7.</citation>
    <PMID>25293374</PMID>
  </results_reference>
  <results_reference>
    <citation>Gross CR, Messersmith EE, Hong BA, Jowsey SG, Jacobs C, Gillespie BW, Taler SJ, Matas AJ, Leichtman A, Merion RM, Ibrahim HN; RELIVE Study Group. Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant. 2013 Nov;13(11):2924-34. doi: 10.1111/ajt.12434. Epub 2013 Sep 6.</citation>
    <PMID>24011252</PMID>
  </results_reference>
  <results_reference>
    <citation>Noppakun K, Cosio FG, Dean PG, Taler SJ, Wauters R, Grande JP. Living donor age and kidney transplant outcomes. Am J Transplant. 2011 Jun;11(6):1279-86. doi: 10.1111/j.1600-6143.2011.03552.x. Epub 2011 May 12.</citation>
    <PMID>21564530</PMID>
  </results_reference>
  <results_reference>
    <citation>Messersmith EE, Gross CR, Beil CA, Gillespie BW, Jacobs C, Taler SJ, Merion RM, Jowsey SG, Leichtman AB, Hong BA; RELIVE Study Group. Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes. Transplantation. 2014 Dec 27;98(12):1294-300. doi: 10.1097/TP.0000000000000360.</citation>
    <PMID>25136843</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>February 5, 2008</study_first_submitted>
  <study_first_submitted_qc>February 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2008</study_first_posted>
  <last_update_submitted>March 23, 2017</last_update_submitted>
  <last_update_submitted_qc>March 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney transplant</keyword>
  <keyword>Live donor transplant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>SDY289</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY289</doc_url>
      <doc_comment>ImmPort study identifier is SDY289</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>SDY289</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY289</doc_url>
      <doc_comment>ImmPort study identifier is SDY289</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>SDY289</doc_id>
      <doc_type>Study summary, -design, -demographics, -files</doc_type>
      <doc_url>http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY289</doc_url>
      <doc_comment>ImmPort study identifier is SDY289</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

